Recombinant Human PSMB8 Protein，His

PSMB8, a core component of the immunoproteasome, plays a critical role in the degradation of intracellular proteins, particularly in immune responses and regulation of inflammation. It is part of the multicatalytic proteinase complex, which is essential for generating peptide fragments that are presented by major histocompatibility complex (MHC) class I molecules to CD8+ T cells, a process vital for the immune system's ability to detect and eliminate infected or cancerous cells. Given its significance in immunological processes, PSMB8 has emerged as a target of interest in studies related to autoimmune diseases, cancer, and viral infections. Dysregulation of PSMB8 has been implicated in various pathological conditions, including multiple sclerosis and certain malignancies, underscoring its potential as a biomarker and therapeutic target. The exploration of recombinant PSMB8 proteins enables researchers to delve into its biological functions, interactions, and mechanisms of action. By examining the structural and functional properties of PSMB8 through recombinant technology, scientists aim to uncover its role in immune modulation and to assess its potential in developing novel therapeutic strategies. Overall, the study of PSMB8 and its recombinant forms represents a promising avenue for enhancing our understanding of immune system regulation and for identifying new opportunities for intervention in immune-related diseases.